Notice of Republication
An incorrect version of S2 File was published in error. This article was republished on April 2, 2019 to correct for this error. Please download this article again to view the correct version.
Reference
- 1. Motoya S, Watanabe K, Ogata H, Kanai T, Matsui T, Suzuki Y, et al. (2019) Vedolizumab in Japanese patients with ulcerative colitis: A Phase 3, randomized, double-blind, placebo-controlled study. PLoS ONE 14(2): e0212989. https://doi.org/10.1371/journal.pone.0212989
Citation: Motoya S, Watanabe K, Ogata H, Kanai T, Matsui T, Suzuki Y, et al. (2019) Correction: Vedolizumab in Japanese patients with ulcerative colitis: A Phase 3, randomized, double-blind, placebo-controlled study. PLoS ONE 14(4): e0215491. https://doi.org/10.1371/journal.pone.0215491
Published: April 11, 2019
Copyright: © 2019 Motoya et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.